- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-hexamer
- Ligands
- 9 x ACT: ACETATE ION(Non-functional Binders)
- 6 x NA: SODIUM ION(Non-functional Binders)
NA.3: 5 residues within 4Å:- Ligands: ACT.2, ACT.9, NA.10, ACT.16, NA.17
No protein-ligand interaction detected (PLIP)NA.4: 2 residues within 4Å:- Ligands: ACT.2, ACT.5
No protein-ligand interaction detected (PLIP)NA.10: 5 residues within 4Å:- Ligands: ACT.2, NA.3, ACT.9, ACT.16, NA.17
No protein-ligand interaction detected (PLIP)NA.11: 2 residues within 4Å:- Ligands: ACT.9, ACT.12
No protein-ligand interaction detected (PLIP)NA.17: 5 residues within 4Å:- Ligands: ACT.2, NA.3, ACT.9, NA.10, ACT.16
No protein-ligand interaction detected (PLIP)NA.18: 2 residues within 4Å:- Ligands: ACT.16, ACT.19
No protein-ligand interaction detected (PLIP)- 3 x 3OX: (2S,4S)-4-HYDROXY-2-(1-METHYLETHYL)-4-[(4R,13S)-18-[METHYL(METHYLSULFONYL)AMINO]-2,15-DIOXO-4-PHENYL-11-OXA-3,14-DIAZATRICYCLO[14.3.1.1~5,9~]HENICOSA-1(20),5(21),6,8,16,18-HEXAEN-13-YL]-N-(2-METHYLPROPYL)BUTANAMIDE(Non-covalent)
3OX.6: 24 residues within 4Å:- Chain A: Q.19, D.38, G.40, S.41, R.82, Y.83, S.84, T.85, P.118, F.119, L.121, F.124, Q.135, I.137, D.226, G.228, A.229, S.230, Y.231, I.232, S.233, H.301, M.303
- Ligands: ACT.1
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:Q.19, A:T.85, A:P.118, A:F.119, A:L.121, A:Q.135, A:I.137
- Hydrogen bonds: A:D.38, A:G.40, A:G.40, A:S.84, A:T.85, A:G.228, A:S.230
- pi-Stacking: A:F.124
3OX.13: 24 residues within 4Å:- Chain C: Q.19, D.38, G.40, S.41, R.82, Y.83, S.84, T.85, P.118, F.119, L.121, F.124, Q.135, I.137, D.226, G.228, A.229, S.230, Y.231, I.232, S.233, H.301, M.303
- Ligands: ACT.8
16 PLIP interactions:16 interactions with chain C- Hydrophobic interactions: C:Q.19, C:T.85, C:P.118, C:F.119, C:L.121, C:Q.135, C:I.137
- Hydrogen bonds: C:D.38, C:G.40, C:G.40, C:S.84, C:T.85, C:G.228, C:S.230, C:H.301
- pi-Stacking: C:F.124
3OX.20: 24 residues within 4Å:- Chain E: Q.19, D.38, G.40, S.41, R.82, Y.83, S.84, T.85, P.118, F.119, L.121, F.124, Q.135, I.137, D.226, G.228, A.229, S.230, Y.231, I.232, S.233, H.301, M.303
- Ligands: ACT.15
16 PLIP interactions:16 interactions with chain E- Hydrophobic interactions: E:Q.19, E:T.85, E:P.118, E:F.119, E:L.121, E:Q.135, E:I.137
- Hydrogen bonds: E:D.38, E:G.40, E:G.40, E:S.84, E:T.85, E:G.228, E:S.230, E:H.301
- pi-Stacking: E:F.124
- 3 x 3OW: (2S,4S)-4-HYDROXY-2-(1-METHYLETHYL)-4-[(4S,13S)-18-[METHYL(METHYLSULFONYL)AMINO]-2,15-DIOXO-4-PHENYL-11-OXA-3,14-DIAZATRICYCLO[14.3.1.1~5,9~]HENICOSA-1(20),5(21),6,8,16,18-HEXAEN-13-YL]-N-(2-METHYLPROPYL)BUTANAMIDE(Non-covalent)
3OW.7: 25 residues within 4Å:- Chain B: T.18, Q.19, Y.20, V.36, D.38, G.40, S.41, R.82, Y.83, S.84, T.85, F.124, Q.135, I.137, Y.162, D.226, T.227, G.228, A.229, S.230, Y.231, S.233, H.301, M.303, I.305
18 PLIP interactions:18 interactions with chain B- Hydrophobic interactions: B:V.36, B:V.36, B:T.85, B:F.124, B:Q.135, B:I.137, B:I.305
- Hydrogen bonds: B:D.38, B:G.40, B:G.40, B:S.84, B:T.85, B:T.85, B:G.228, B:G.228, B:S.230, B:S.233
- pi-Stacking: B:F.124
3OW.14: 25 residues within 4Å:- Chain D: T.18, Q.19, Y.20, V.36, D.38, G.40, S.41, R.82, Y.83, S.84, T.85, F.124, Q.135, I.137, Y.162, D.226, T.227, G.228, A.229, S.230, Y.231, S.233, H.301, M.303, I.305
17 PLIP interactions:17 interactions with chain D- Hydrophobic interactions: D:V.36, D:V.36, D:T.85, D:F.124, D:Q.135, D:I.137, D:I.305
- Hydrogen bonds: D:D.38, D:G.40, D:G.40, D:S.84, D:T.85, D:G.228, D:G.228, D:S.230, D:S.233
- pi-Stacking: D:F.124
3OW.21: 25 residues within 4Å:- Chain F: T.18, Q.19, Y.20, V.36, D.38, G.40, S.41, R.82, Y.83, S.84, T.85, F.124, Q.135, I.137, Y.162, D.226, T.227, G.228, A.229, S.230, Y.231, S.233, H.301, M.303, I.305
18 PLIP interactions:18 interactions with chain F- Hydrophobic interactions: F:V.36, F:V.36, F:T.85, F:F.124, F:Q.135, F:I.137, F:I.305
- Hydrogen bonds: F:D.38, F:G.40, F:G.40, F:S.84, F:T.85, F:T.85, F:G.228, F:G.228, F:S.230, F:S.233
- pi-Stacking: F:F.124
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sund, C. et al., Design and synthesis of potent macrocyclic renin inhibitors. Bioorg.Med.Chem.Lett. (2011)
- Release Date
- 2010-12-15
- Peptides
- Renin: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-hexamer
- Ligands
- 9 x ACT: ACETATE ION(Non-functional Binders)
- 6 x NA: SODIUM ION(Non-functional Binders)
- 3 x 3OX: (2S,4S)-4-HYDROXY-2-(1-METHYLETHYL)-4-[(4R,13S)-18-[METHYL(METHYLSULFONYL)AMINO]-2,15-DIOXO-4-PHENYL-11-OXA-3,14-DIAZATRICYCLO[14.3.1.1~5,9~]HENICOSA-1(20),5(21),6,8,16,18-HEXAEN-13-YL]-N-(2-METHYLPROPYL)BUTANAMIDE(Non-covalent)
- 3 x 3OW: (2S,4S)-4-HYDROXY-2-(1-METHYLETHYL)-4-[(4S,13S)-18-[METHYL(METHYLSULFONYL)AMINO]-2,15-DIOXO-4-PHENYL-11-OXA-3,14-DIAZATRICYCLO[14.3.1.1~5,9~]HENICOSA-1(20),5(21),6,8,16,18-HEXAEN-13-YL]-N-(2-METHYLPROPYL)BUTANAMIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sund, C. et al., Design and synthesis of potent macrocyclic renin inhibitors. Bioorg.Med.Chem.Lett. (2011)
- Release Date
- 2010-12-15
- Peptides
- Renin: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B